Apolipoprotein B, diabetes and medical consensus.
Sniderman
Allan D
AD
D001055:Apolipoproteins B / Q000097:blood / Q000502:physiology*; D002995:Clofibric Acid / Q000627:therapeutic use; D032921:Consensus; D048909:Diabetes Complications / Q000097:blood / Q000209:etiology*; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy; D003925:Diabetic Angiopathies / Q000209:etiology / Q000517:prevention & control; D050171:Dyslipidemias / Q000209:etiology; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D011364:Professional Practice; D012307:Risk Factors; D017211:Treatment Failure
D001055:Apolipoproteins B; D000960:Hypolipidemic Agents; D002995:Clofibric Acid